Pharmicell Co (XKRX:005690) Ending Cash Position : ₩10,493 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Ending Cash Position?

Pharmicell Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩10,493 Mil.

Pharmicell Co's quarterly Ending Cash Position declined from Sep. 2023 (₩18,677 Mil) to Dec. 2023 (₩13,724 Mil) and declined from Dec. 2023 (₩13,724 Mil) to Mar. 2024 (₩10,493 Mil).

Pharmicell Co's annual Ending Cash Position declined from Dec. 2021 (₩26,211 Mil) to Dec. 2022 (₩14,359 Mil) and declined from Dec. 2022 (₩14,359 Mil) to Dec. 2023 (₩13,724 Mil).

Pharmicell Co Ending Cash Position Historical Data

The historical data trend for Pharmicell Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Ending Cash Position Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

16,704.92

20,938.95

26,211.42

14,358.78

13,724.09

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															17,875.38	23,411.56	18,676.94	13,724.09	10,493.05

Pharmicell Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pharmicell Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14358.78	+	-634.693
	=	13,724

Pharmicell Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13724.086	+	-3231.035
	=	10,493

Pharmicell Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines